Literature DB >> 27449798

Bidirectional Modulation of Extinction of Drug Seeking by Deep Brain Stimulation of the Ventral Striatum.

Freddyson J Martínez-Rivera1, Jose Rodriguez-Romaguera2, Mario E Lloret-Torres1, Fabricio H Do Monte2, Gregory J Quirk3, Jennifer L Barreto-Estrada4.   

Abstract

BACKGROUND: Recent research in humans and rodents has explored the use of deep brain stimulation (DBS) of the ventral capsule/ventral striatum (VS) as a possible treatment for drug addiction. However, the optimum electrode placement and optimum DBS parameters have not been thoroughly studied. Here we varied stimulation sites and frequencies to determine whether DBS of the VS could facilitate the extinction of morphine-induced conditioned place preference in rats.
METHODS: Rats were implanted with DBS electrodes in the dorsal or ventral subregions of the VS and trained to the morphine conditioned place preference. Subsequently, rats received extinction sessions over 9 days, combined with 60 min of either high- (130 Hz) or low- (20 Hz) frequency DBS. To study circuit-wide activations after DBS of the VS, c-fos immunohistochemistry was performed in regions involved in the extinction of drug-seeking behaviors.
RESULTS: High-frequency DBS of the dorsal-VS impaired both extinction training and extinction memory, whereas high-frequency DBS of the ventral-VS had no effect. In contrast, low-frequency DBS of the dorsal-VS strengthened extinction memory when tested 2 or 9 days after the cessation of stimulation. Both DBS frequencies increased c-fos expression in the infralimbic prefrontal cortex, but only low-frequency DBS increased c-fos expression in the basal amygdala and the medial portion of the central amygdala.
CONCLUSIONS: Our results suggest that low-frequency (rather than high-frequency) DBS of the dorsal-VS strengthens extinction memory and may be a potential adjunct for extinction-based therapies for treatment-refractory opioid addiction.
Copyright © 2016 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amygdala; CPP; DBS; Extinction; Morphine; Ventral striatum

Mesh:

Substances:

Year:  2016        PMID: 27449798      PMCID: PMC5507549          DOI: 10.1016/j.biopsych.2016.05.015

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  63 in total

1.  Differential projections of the infralimbic and prelimbic cortex in the rat.

Authors:  Robert P Vertes
Journal:  Synapse       Date:  2004-01       Impact factor: 2.562

Review 2.  Deep brain stimulation for the treatment of addiction: basic and clinical studies and potential mechanisms of action.

Authors:  R Christopher Pierce; Fair M Vassoler
Journal:  Psychopharmacology (Berl)       Date:  2013-08-02       Impact factor: 4.530

3.  Deep brain stimulation of the nucleus accumbens shell attenuates cocaine reinstatement through local and antidromic activation.

Authors:  Fair M Vassoler; Samantha L White; Thomas J Hopkins; Leonardo A Guercio; Julie Espallergues; Olivier Berton; Heath D Schmidt; R Christopher Pierce
Journal:  J Neurosci       Date:  2013-09-04       Impact factor: 6.167

4.  Extinction of drug- and withdrawal-paired cues in animal models: relevance to the treatment of addiction.

Authors:  Karyn M Myers; William A Carlezon
Journal:  Neurosci Biobehav Rev       Date:  2010-01-28       Impact factor: 8.989

5.  PKMζ maintains drug reward and aversion memory in the basolateral amygdala and extinction memory in the infralimbic cortex.

Authors:  Ying-Ying He; Yan-Xue Xue; Ji-Shi Wang; Qin Fang; Jian-Feng Liu; Li-Fen Xue; Lin Lu
Journal:  Neuropsychopharmacology       Date:  2011-06-01       Impact factor: 7.853

6.  Deep brain stimulation of the nucleus accumbens and its usefulness in severe opioid addiction.

Authors:  J Kuhn; M Möller; J F Treppmann; C Bartsch; D Lenartz; T O J Gruendler; M Maarouf; A Brosig; U B Barnikol; J Klosterkötter; V Sturm
Journal:  Mol Psychiatry       Date:  2013-01-22       Impact factor: 15.992

7.  Excitant amino acid projections from rat amygdala and thalamus to nucleus accumbens.

Authors:  T G Robinson; P M Beart
Journal:  Brain Res Bull       Date:  1988-04       Impact factor: 4.077

8.  Stimulation of dopamine D2/D3 but not D1 receptors in the central amygdala decreases cocaine-seeking behavior.

Authors:  Kenneth J Thiel; Jennifer M Wenzel; Nathan S Pentkowski; Rebecca J Hobbs; Andrea T Alleweireldt; Janet L Neisewander
Journal:  Behav Brain Res       Date:  2010-06-19       Impact factor: 3.332

9.  Modulation of epileptic activity by deep brain stimulation: a model-based study of frequency-dependent effects.

Authors:  Faten Mina; Pascal Benquet; Anca Pasnicu; Arnaud Biraben; Fabrice Wendling
Journal:  Front Comput Neurosci       Date:  2013-07-16       Impact factor: 2.380

10.  The Plasticity of Extinction: Contribution of the Prefrontal Cortex in Treating Addiction through Inhibitory Learning.

Authors:  J T Gass; L J Chandler
Journal:  Front Psychiatry       Date:  2013-05-30       Impact factor: 4.157

View more
  20 in total

1.  Subthalamic low-frequency oscillations predict vulnerability to cocaine addiction.

Authors:  Mickael Degoulet; Alix Tiran-Cappello; Etienne Combrisson; Christelle Baunez; Yann Pelloux
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-06       Impact factor: 11.205

2.  Neuroplasticity transcript profile of the ventral striatum in the extinction of opioid-induced conditioned place preference.

Authors:  Freddyson J Martínez-Rivera; Namyr A Martínez; Magdiel Martínez; Roxsana N Ayala-Pagán; Walter I Silva; Jennifer L Barreto-Estrada
Journal:  Neurobiol Learn Mem       Date:  2019-06-04       Impact factor: 2.877

Review 3.  Deep brain stimulation for the treatment of drug addiction.

Authors:  Tony R Wang; Shayan Moosa; Robert F Dallapiazza; W Jeffrey Elias; Wendy J Lynch
Journal:  Neurosurg Focus       Date:  2018-08       Impact factor: 4.047

Review 4.  A Motivational and Neuropeptidergic Hub: Anatomical and Functional Diversity within the Nucleus Accumbens Shell.

Authors:  Daniel C Castro; Michael R Bruchas
Journal:  Neuron       Date:  2019-05-08       Impact factor: 17.173

Review 5.  The Mesolimbic Dopamine System in Chronic Pain and Associated Affective Comorbidities.

Authors:  Randal A Serafini; Kerri D Pryce; Venetia Zachariou
Journal:  Biol Psychiatry       Date:  2020-01-01       Impact factor: 13.382

6.  Deep brain stimulation of the nucleus accumbens shell attenuates cocaine withdrawal but increases cocaine self-administration, cocaine-induced locomotor activity, and GluR1/GluA1 in the central nucleus of the amygdala in male cocaine-dependent rats.

Authors:  Marsida Kallupi; Jenni Kononoff; Philippe A Melas; Johanna S Qvist; Giordano de Guglielmo; Eric R Kandel; Olivier George
Journal:  Brain Stimul       Date:  2021-11-03       Impact factor: 8.955

7.  Modulating Morphine Context-Induced Drug Memory With Deep Brain Stimulation: More Research Questions by Lowering Stimulation Frequencies?

Authors:  Meaghan Creed; Antonello Bonci; Lorenzo Leggio
Journal:  Biol Psychiatry       Date:  2016-11-01       Impact factor: 13.382

8.  Reply to: Does High-Frequency Deep Brain Stimulation in Dorsal Regions of the Ventral Striatum Impair Extinction of Morphine-Induced Place Preference?

Authors:  Freddyson J Martínez-Rivera; Jennifer L Barreto-Estrada
Journal:  Biol Psychiatry       Date:  2017-06-10       Impact factor: 13.382

Review 9.  BEHAVIORAL AND NEUROBIOLOGICAL MECHANISMS OF PAVLOVIAN AND INSTRUMENTAL EXTINCTION LEARNING.

Authors:  Mark E Bouton; Stephen Maren; Gavan P McNally
Journal:  Physiol Rev       Date:  2020-09-24       Impact factor: 37.312

10.  High-Frequency Deep Brain Stimulation of the Substantia Nigra Pars Reticulata Facilitates Extinction and Prevents Reinstatement of Methamphetamine-Induced Conditioned Place Preference.

Authors:  Libo Zhang; Shiqiu Meng; Wenjun Chen; Yun Chen; Enze Huang; Guipeng Zhang; Yisen Liang; Zengbo Ding; Yanxue Xue; Yun Chen; Jie Shi; Yu Shi
Journal:  Front Pharmacol       Date:  2021-06-30       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.